Extracorporeal Membrane Oxygenation Machine (ECMO) Market Research Report By Application (Cardiac Support, Respiratory Support, Cardiopulmonary Bypass), By End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings), By Product Type (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO), By Component (Membrane Oxygenator, Blood Pumps, Heat Exchangers) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Overview

As per MRFR analysis, the Extracorporeal Membrane Oxygenation Machine (ECMO) Market Size was estimated at 1.76 (USD Billion) in 2023.The Extracorporeal Membrane Oxygenation Machine (ECMO) Market Industry is expected to grow from 1.86(USD Billion) in 2024 to 3.5 (USD Billion) by 2035. The Extracorporeal Membrane Oxygenation Machine (ECMO) Market CAGR (growth rate) is expected to be around 5.89% during the forecast period (2025 - 2035).

Key Extracorporeal Membrane Oxygenation Machine (ECMO) Market Trends Highlighted

The Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market has been experiencing significant advancements and shifts driven by several key market drivers. The increasing prevalence of respiratory and cardiac diseases, particularly in aging populations, is fueling the demand for ECMO machines, as these devices are critical in providing life support to patients with severe heart and lung conditions. 

Additionally, technological innovations, such as miniaturization and improved biocompatibility of ECMO devices, are likely enhancing their functionality and user-friendliness, making them more accessible to healthcare providers.  Opportunities in the market continue to expand as awareness of ECMO therapy grows among healthcare professionals and patients alike.Governments and healthcare organizations are increasingly investing in advanced healthcare infrastructure, prioritizing regions with high rates of chronic respiratory diseases.

This trend presents a chance for manufacturers to collaborate with healthcare facilities to increase the adoption of ECMO technologies and broaden their market reach.  Trends in recent times indicate a growing focus on the development of portable ECMO devices that can be used in various settings, including hospitals, out-patient clinics, and even in emergency situations. Such versatility may pave the way for ECMO therapy to be utilized earlier in the treatment process, potentially improving patient outcomes.

Furthermore, global initiatives aimed at improving critical care capabilities, particularly in developing regions, could lead to a surge in demand for ECMO machines as part of emergency medical services. Overall, the combination of increasing disease prevalence, technological advancements, and growing awareness position the Global ECMO market for steady growth in the coming years.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Drivers

The rise in Respiratory and Cardiac Diseases

One of the main factors propelling the global extracorporeal membrane oxygenation machine (ECMO) market is the rising incidence of respiratory and cardiovascular disorders worldwide. The World Health Organization estimates that cardiovascular illnesses account for 17.9 million deaths annually, making them the world's top cause of mortality. Furthermore, according to recent predictions, 251 million individuals worldwide are expected to suffer from respiratory conditions, including chronic obstructive pulmonary disease.

Hospitals and other healthcare institutions are adopting modern medical technology, such as ECMO, for emergency patients as a result of the rising health burden. The Global Initiative for Chronic Obstructive Lung Disease and the American Heart Association are two well-known organizations that actively support and raise awareness of research and development initiatives, which are essential to the expansion of the ECMO industry in many areas.

,Technological Advancements in ECMO Systems

Recent technological innovations in ECMO systems, such as miniaturization and enhanced monitoring capabilities, are fueling the Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market Industry. The integration of automation and digitalization in these systems allows for improved patient management and reduces the chance of human error.

According to a report by the European Society of Cardiology, technological advancements have led to a 50% reduction in the complexity of ECMO setups over the past decade.This enhanced usability opens opportunities for wider adoption in various healthcare settings, including emergency rooms and intensive care units. Leading medical device manufacturers are allocating significant resources to Research and Development, which continues to drive innovation in ECMO technology.

Increased Funding for Healthcare Infrastructure

Governments around the globe are making substantial investments to improve healthcare infrastructure, particularly post-COVID-19. These investments are aimed at boosting the capacity to handle critical care patients, thus driving the demand for ECMO systems. The Global Health Expenditure database shows that countries like the United Kingdom and Germany have raised their healthcare budgets by approximately 7-10% in the last two fiscal years alone to advance healthcare capabilities.

This trend encourages hospitals to upgrade their facilities and integrate advanced technologies like Extracorporeal Membrane Oxygenation machines, thereby propelling the growth of the Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market Industry.

Growing Awareness and Training Programs

There is an increasing emphasis on education and training programs for healthcare professionals regarding the use of ECMO, which is essential for improving clinical outcomes in critical care. Institutions like the Extracorporeal Life Support Organization have been instrumental in providing extensive training modules and hosting workshops and conferences worldwide that aim to train over 10,000 healthcare professionals each year in proper ECMO utilization and management.This surge in knowledge and skill has resulted in a greater adoption rate of ECMO technology in hospitals and intensive care units globally. Enhanced training leads to better patient outcomes, thereby boosting the demand for the Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market Industry.

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Segment Insights

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Application Insights

The Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market is witnessing significant growth across various applications, indicating a robust focus on critical care and advanced respiratory and cardiac support. In 2024, the market is valued at 1.86 billion USD, with the Application segment playing a crucial role in catering to patients requiring life-saving interventions. 

This segment comprises three primary applications: Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass. Among these applications, Cardiac Support is projected to dominate the market, valued at 0.85 billion USD in 2024 and expected to grow to 1.6 billion USD by 2035. This surge in valuation reflects the increasing prevalence of heart diseases and the growing need for cardiac surgeries, driving demand for ECMO machines that provide vital support to critically ill patients.

Respiratory Support, valued at 0.75 billion USD in 2024 and anticipated to expand to 1.3 billion USD by 2035, is another significant component of the ECMO landscape. The rising incidence of respiratory disorders, including COVID-19 and other severe lung conditions, has underscored the necessity for effective and advanced respiratory support technologies, further bolstering the importance of this application. The Cardiopulmonary Bypass application, although smaller in comparison, plays a vital role in certain surgical procedures; it is valued at 0.26 billion USD in 2024 and is expected to reach 0.6 billion USD by 2035.

This segment is expected to experience growth driven by an increase in surgical procedures and advancements in ECMO technology. The strategic relevance of these applications lies in their ability to provide temporary support, significantly improving survival rates for critically ill patients. Furthermore, the trends in clinical settings have begun emphasizing personalized medicine and technology integration, which facilitates enhancements in patient outcomes and safety profiles. Overall, the Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market segmentation reflects a growing acknowledgment of the necessity for innovative solutions in critical care, bolstered by evolving treatment protocols and the increasing demand for effective cardiac and respiratory support systems.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Extracorporeal Membrane Oxygenation Machine (ECMO) Market End User Insights

The Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market, particularly within the End User segment, is expected to play a crucial role in the healthcare landscape. In 2024, the market is achieved a significant revenue, reflecting growing demand and utilization in various healthcare settings, particularly hospitals, which primarily cater to critically ill patients requiring advanced respiratory support and cardiac functionality.

Ambulatory Surgical Centers are also becoming increasingly recognized for their efficiency in providing ECMO services, presenting a notable opportunity as they are equipped to manage less complex cases and enable quicker patient recovery.Home Care Settings represent a growing trend in the Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market, offering patients the necessary care in the comfort of their homes, which is especially beneficial for long-term management.

Collectively, these End User categories illustrate a dynamic landscape, supporting healthcare advancements and addressing the increasing prevalence of respiratory and cardiovascular conditions globally, driven by factors such as technological developments, an aging population, and greater healthcare access. This segmentation highlights the varied applications of ECMO, reinforcing its importance in both acute and long-term care scenarios, thus impacting overall Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market data and statistics.

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Product Type Insights  

The Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market is experiencing significant growth driven by advancements in medical technology and the increasing prevalence of respiratory and cardiac diseases. In 2024, the market is valued at 1.86 USD Billion, with a notable upward trend as it is projected to reach 3.5 USD Billion by 2035. Among the product types, Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO play pivotal roles in addressing critical medical conditions.

Venoarterial ECMO primarily supports patients with severe cardiac issues, providing life-saving interventions by oxygenating blood while bypassing the heart, which is crucial during cardiac surgeries or heart failure.In contrast, Venovenous ECMO is essential for patients suffering from severe respiratory failure, facilitating oxygen delivery without the need for traditional mechanical ventilation, thereby enhancing patient comfort. Arteriovenous ECMO also serves a critical function in specific surgical situations.

The increasing acceptance of these therapies and ongoing innovations in ECMO technologies are prominent factors propelling the market forward, supported by the growing focus on improving clinical outcomes and the availability of trained healthcare professionals globally.As the Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market continues to evolve, these product types will remain integral to contemporary critical care medicine.

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Component Insights  

The Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market emphasizes the critical role of its Component segment, comprising essential elements such as Membrane Oxygenators, Blood Pumps, and Heat Exchangers. With the overall market is valued at 1.86 USD Billion in 2024, these components are pivotal in ensuring effective respiratory and cardiac assistance for patients with severe heart and lung conditions.

Membrane Oxygenators are significant as they facilitate gas exchange, directly impacting patient outcomes, while Blood Pumps play a crucial role in maintaining hemodynamic stability by ensuring proper blood flow.Heat Exchangers are vital for temperature management and preventing hypothermia during procedures. The growing incidence of respiratory ailments and the increasing adoption of ECMO in critical care settings underscore the importance of these components.

Market trends reveal a shift toward advanced technologies and improved designs, aiming to enhance patient safety and efficiency of ECMO devices. However, challenges such as the high cost of ECMO systems and the need for skilled personnel to operate them present opportunities for innovation and growth within the industry.This array of components ultimately underlines the significance of the Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market revenue and its continuous evolution in meeting clinical demands.

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Regional Insights

The Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market exhibits notable segmentation across various regions, which is essential for understanding market dynamics. In 2024, the North American segment holds a significant valuation of 0.8 USD Billion and is projected to reach 1.46 USD Billion by 2035, indicating its majority holding in the market due to advanced healthcare infrastructure and rising demand for ECMO procedures.

Europe follows closely, with a valuation of 0.6 USD Billion in 2024 and 1.1 USD Billion in 2035, driven by increasing investments in healthcare technology and growing awareness about ECMO benefits.The Asia-Pacific (APAC) region, valued at 0.32 USD Billion in 2024 and 0.62 USD Billion in 2035, demonstrates a rapid growth trajectory attributed to improving healthcare services and increasing prevalence of respiratory diseases, making it a significant player in the ECMO market.

South America and the Middle East and Africa (MEA) sub-regions, although comparatively smaller, represent important emerging markets with projected valuations of 0.08 USD Billion and 0.06 USD Billion in 2024, highlighting growing healthcare initiatives and potential opportunities.Overall, these figures provide key insights into the competitive landscape and regional trends impacting the Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Key Players and Competitive Insights

The Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market has witnessed significant developments and competitive dynamics in recent years. ECMO machines are critical in providing life support for patients with severe respiratory or cardiac failure, and their advanced technology plays a crucial role in enhancing patient survival rates. The market is characterized by a mix of established players and emerging companies, each striving to offer innovative solutions that cater to the needs of healthcare facilities globally. The competitive landscape is driven by factors such as technological advancements, strategic collaborations, and an increasing prevalence of chronic diseases requiring ECMO support.

These dynamics create a diverse marketplace where companies compete vigorously for market share.Getinge has positioned itself as a key player in the Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market, with a strong emphasis on delivering high-quality medical devices that support critical care. The company is known for its advanced ECMO solutions, which are designed to optimize patient care and enhance the efficiency of healthcare providers. Getinge's strengths lie in its robust R&D capabilities, allowing it to innovate and introduce cutting-edge technologies that meet the evolving demands of the medical field. Additionally, the company's extensive distribution networks and long-term partnerships with healthcare institutions have solidified its presence in the global market, enabling it to quickly adapt to regional requirements while maintaining a reputation for reliability and excellence in critical care.

Xenios AG has also made a significant mark in the Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market, focusing on innovative solutions that address complex clinical needs. The company specializes in developing advanced ECMO systems that incorporate the latest technologies in blood oxygenation and mechanical ventilation. Xenios AG's product offerings are designed to optimize the treatment of patients with severe respiratory and cardiac conditions, allowing for prolonged support in critical situations. 

The company's strengths include its commitment to research and development, leading to the continuous enhancement of existing products and the introduction of new solutions. Moreover, Xenios AG has demonstrated a proactive approach to mergers and acquisitions, which has expanded its product portfolio and market presence, allowing for greater competitiveness in the global arena. This strategic focus not only bolsters its market position but also enhances its ability to deliver comprehensive care solutions tailored to the needs of healthcare providers worldwide.

Key Companies in the Extracorporeal Membrane Oxygenation Machine (ECMO) Market Include

• Getinge


• Xenios AG


• Fresenius Medical Care


• LivaNova


• Maquet


• Terumo


• Nipro


• Jiangsu Huaxi Medical Equipment


• Medtronic


• Avauncer


• Elekta


• MediStim


• Hitachi


• Sewon Medical

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Industry Developments

Recent developments in the Global Extracorporeal Membrane Oxygenation Machine (ECMO) Market include significant advancements in technology and growing demand due to increased cases of respiratory and cardiac failures globally. Companies such as Getinge and Fresenius Medical Care are focusing on enhancing their product offerings through innovative designs and improved functionalities. The acquisition landscape has recently seen notable activity, particularly in April 2023, when Terumo finalized its acquisition of a smaller medical device company, strengthening its ECMO product line and expanding its market reach. 

Market valuations have seen growth, with reports indicating a surge in demand leading to heightened investments in Research and Development among companies like LivaNova and Medtronic, which are working to improve the efficiency of ECMO systems. In 2022, the COVID-19 pandemic prompted a notable reliance on ECMO machines, accelerating the production and deployment of these devices globally. Noteworthy occurrences in the past 2-3 years have led to heightened collaboration among medical institutions to develop ECMO training and protocol standards. This period has catalyzed an extensive review of regulatory frameworks, aiming to expedite the approval process for newer ECMO technologies in various markets around the world.

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Segmentation Insights

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Application Outlook

• Cardiac Support


• Respiratory Support


• Cardiopulmonary Bypass

Extracorporeal Membrane Oxygenation Machine (ECMO) Market End User Outlook

• Hospitals


• Ambulatory Surgical Centers


• Home Care Settings

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Product Type Outlook

• Venoarterial ECMO


• Venovenous ECMO


• Arteriovenous ECMO

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Component Outlook

• Membrane Oxygenator


• Blood Pumps


• Heat Exchangers

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa

Report Attribute/Metric	Details
Market Size 2023	1.76(USD Billion)
Market Size 2024	1.86(USD Billion)
Market Size 2035	3.5(USD Billion)
Compound Annual Growth Rate (CAGR)	5.89% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024

Market Forecast Units	USD Billion
Key Companies Profiled	Sorin Group, Maquet, Hamilton Medical, Fresenius SE  and  Co. KGaA, MediCorp, Ciel Medical, Nipro Corporation, Braun Melsungen AG, Fabian Medical, Asahi Kasei Medical, LivaNova, Cardinal Health, Medtronic, Terumo, Getinge
Segments Covered	Application, Type, End Use, Component, Regional
Key Market Opportunities	Technological advancements in ECMO, Rising prevalence of respiratory diseases, Increasing investments in healthcare infrastructure, Growing demand for portable ECMO systems, Expansion into emerging markets
Key Market Dynamics	Rising prevalence of respiratory diseases, Technological advancements in ECMO systems, Increasing healthcare expenditure, Growing awareness of ECMO benefits, Strong demand for emergency care
Countries Covered	North America, Europe, APAC, South America, MEA